NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa

Pharma and biotech companies at NSGC 2026

Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website

21 pharma and biotech companies are at NSGC 2026 — 7 presentations on the program and 21 with a booth in the exhibit hall. 21 of them have their own page in this guide. As of Nov 12, 2026.

All 86 organizations at NSGC 2026 →

Topic
Showing 1–17 of 21 organizations
OrganizationNSGC 2026 Attendance
Pharma and biotech companies
Biopharmaceutical company with approved treatments for Rett syndrome and Parkinson's disease psychosis, developing further medicines for neurological and rare conditions.
Booth
Exhibiting at Booth 963
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
Rett Syndrome Management Your Way: Two Formulations of the First and Only FDA-Approved Treatment
Covers Rett syndrome care with both forms of Acadia's FDA-approved Rett treatment, DAYBUE and DAYBUE STIX.
Neurology · Rare disease
Pharma and biotech companies
AstraZeneca's rare disease company, with medicines for conditions including hypophosphatasia, lysosomal acid lipase deficiency, neurofibromatosis type 1 and complement disorders.
Booth
Exhibiting at Booth 1155
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
12:15–1:30pm
Recognize What Might Be Missed: Changing the Patient Journey in HPP, LAL-D, NF1
Reviews the clinical clues to hypophosphatasia, lysosomal acid lipase deficiency and neurofibromatosis type 1, to help clinicians recognize them earlier.
Rare disease
Ascendis Pharma
Copenhagen, Denmark
Pharma and biotech companies
Biopharmaceutical company developing long-acting treatments for rare endocrine and skeletal conditions, including achondroplasia.
Booth
Exhibiting at Booth 1055
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
7:45–8:30am
Discover Yuviwel® (navepegritide)
Introduces Ascendis' Yuviwel (navepegritide), covering how it works, its clinical trial results and how it is dosed.
Rare disease
BioMarin
San Rafael, CA
Pharma and biotech companies
Biotech company with medicines for rare genetic conditions, including achondroplasia and other skeletal disorders, PKU and several lysosomal storage disorders.
Booth
Exhibiting at Booth 1150, 1243, 1342
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Thu Nov 12
7:45–8:30am
Hypochondroplasia: Advancing Diagnosis and Genetic Counseling in an Evolving Clinical Landscape
Follows patients with hypochondroplasia from first suspicion to genetic confirmation and counseling, including FGFR3 variant interpretation and emerging treatments.
Rare disease
BridgeBio
Palo Alto, CA
Pharma and biotech companies
Biotech company developing medicines for genetic conditions, including transthyretin amyloid cardiomyopathy and achondroplasia.
Booth
Exhibiting at Booth 1247, 1347
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
One Diagnosis, Many Conversations: The Evolving Landscape of Care in Achondroplasia and the Role of Genetic Counselors
Traces achondroplasia care from prenatal recognition through childhood treatment choices to adult family planning, and the genetic counselor's role throughout.
Rare disease
Lilly
Indianapolis, IN
Pharma and biotech companies
Global pharmaceutical company whose genetic medicine work includes gene therapy for hereditary hearing loss; sponsors a session on hearing loss genetic testing.
Booth
Exhibiting at Booth 1363
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
Partners in Diagnosis: Collaborative Models for Genetic Testing and Counseling in Hereditary Hearing Loss
Uses hereditary hearing loss to show how genetic counselors, audiologists and otolaryngologists can team up so genetic testing is routinely offered.
Rare disease
Sanofi
Paris, France
Pharma and biotech companies
Global pharmaceutical company with rare disease medicines, including enzyme replacement therapies for Gaucher, Pompe and Fabry disease.
Booth
Exhibiting at Booth 1148, 1165
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
12:15–1:30pm
One Rare Disease, Three Perspectives: How Genetic Counselors Across Clinic, Research, and Industry Shape Patient Care
Uses Gaucher disease type 3 to show how genetic counselors in clinics, research and industry each shape diagnosis and care.
Rare disease
Pharma and biotech companies
Biotech company, now a BioMarin subsidiary, with treatments for the lysosomal storage disorders Fabry disease and Pompe disease.
Booth
Exhibiting at Booth 1352
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Biotech company developing RNA interference medicines, including treatments for severe triglyceride disorders and homozygous familial hypercholesterolemia.
Booth
Exhibiting at Booth 1050
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Public benefit biotech company developing adrabetadex, an investigational treatment for Niemann-Pick disease type C.
Booth
Exhibiting at Booth 1254
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Rare disease unit of the Chiesi Group developing treatments for lysosomal storage disorders such as Fabry disease and alpha-mannosidosis.
Booth
Exhibiting at Booth 1456
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Biotech company developing treatments for rare neurodegenerative diseases, including Niemann-Pick disease type C.
Booth
Exhibiting at Booth 1246
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Biotech company developing RNA-targeted medicines, with marketed drugs and a pipeline in neurology, cardiology and rare diseases.
Booth
Exhibiting at Booth 1070
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Biotech company developing therapies for diseases caused by mitochondrial dysfunction, aiming to correct cellular energy deficits.
Booth
Exhibiting at Booth 1361
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Mirum Pharmaceuticals
Foster City, CA
Pharma and biotech companies
Biopharmaceutical company with medicines for rare diseases, including rare cholestatic liver diseases and fibrodysplasia ossificans progressiva.
Booth
Exhibiting at Booth 1276
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pfizer
New York, NY
Pharma and biotech companies
Global pharmaceutical company whose oncology unit develops small molecules, antibody-drug conjugates and bispecifics for breast, genitourinary, blood and lung cancers.
Booth
Exhibiting at Booth 1478
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Pharma and biotech companies
Biopharmaceutical company with medicines for rare genetic diseases, including Duchenne muscular dystrophy, AADC deficiency and phenylketonuria (PKU).
Booth
Exhibiting at Booth 1253
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm

Explore the full NSGC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Baltimore. Leave your work email and we’ll be in touch.

Privacy

Download the full NSGC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from pharma and biotech companies

Tell us what you sell and we’ll find the people at these pharma and biotech companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse NSGC 2026 by

Exhibit hall

Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction